Non-adherence – The largest contribution to variability in drug response

Wednesday 16th of April 2014
SY28, 1.5 hours

Chair: Michael Wiese (Australia)

Meeting room 211

10.30 – 11.00     Scope of patient non-adherence to prescribed drug dosing regimes
(WE-14-01) John Urquhart , MWV Healthcare, Visé, Belgium and UCSF, San Francisco, CA, USA

11.00 – 11.30     The CMC issues surrounding adherence associated with pediatric and geriatic populations
(WE-14-02) Alastair Coupe, Pfizer, Kent, United Kingdom

11.30 – 12.00     Utilising technology to improve adherence and patient outcomes
(WE-14-03) Greg Peterson, University of Tasmania, Hobart, Australia